Recent research I've read about appears to suggest an interesting venue for
handling aggressive tumor cells, such aa adenocarcinomas. It is a new
vaccine from genetically engineered cells, reserached mostly, I belive, at
UCLA. The vaccine would prevent malignant cells from producing TGF-beta, and
would therefore presumably allow the immune system to function. My
understanding is that TGF-beta cloaks the cancer cells, thus supressing the
immune system and protecting the cancer. With the vaccine, the immune system
would function in an unimpeded manner. Do anyone know where there are
clinical trials on this agent,and who would be the contact person. Your help
would be much appreciated.
Thank you,
Howard Katz HKATZ@IS.MGH.MCGILL.CA
